Skip to main content
. 2017 Oct 13;142(3):618–628. doi: 10.1002/ijc.31070

Figure 2.

Figure 2

Kaplan–Meier survival analyses. (a) EFS and (b) OS for all patients in the trial (N = 149). (c) EFS and (d) OS for patients with basal tumors (N = 26).